Dr. Reddy launches Sildenafil tablets

India Infoline News Service | Mumbai | November 19, 2012 09:51 IST

The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.

Dr. Reddy's Laboratories announced today that it has launched Sildenafil Tablets (20 mg), a bioequivalent generic version of REVATIO® (Sildenafil) Tablets in the US market on November16, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Sildenafil Tablets.


The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.


Dr. Reddy's Sildenafil Tablets in 20 mg are available in 90 count bottle sizes.

BSE 3,012.10 [82.20] ([2.66]%)
NSE 3,011.80 [76.90] ([2.49]%)

***Note: This is a NSE Chart